Vanguard Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,076,789
| Closed | -$2.86M | – | 4507 |
|
|
2024
Q1 | $2.86M | Buy |
1,076,789
+33,879
| +3% | +$90.1K | ﹤0.01% | 3481 |
|
|
2023
Q4 | $2.47M | Buy |
1,042,910
+48,698
| +5% | +$115K | ﹤0.01% | 3529 |
|
|
2023
Q3 | $1.39M | Hold |
994,212
| – | – | ﹤0.01% | 3720 |
|
|
2023
Q2 | $3.01M | Sell |
994,212
-30,474
| -3% | -$92.3K | ﹤0.01% | 3518 |
|
|
2023
Q1 | $6.4M | Buy |
1,024,686
+6,746
| +0.7% | +$42.2K | ﹤0.01% | 3188 |
|
|
2022
Q4 | $6.21M | Buy |
1,017,940
+6,593
| +0.7% | +$40.2K | ﹤0.01% | 3199 |
|
|
2022
Q3 | $12.1M | Buy |
1,011,347
+15,270
| +2% | +$182K | ﹤0.01% | 2862 |
|
|
2022
Q2 | $12.6M | Sell |
996,077
-459,557
| -32% | -$5.8M | ﹤0.01% | 2865 |
|
|
2022
Q1 | $16.4M | Sell |
1,455,634
-466,789
| -24% | -$5.26M | ﹤0.01% | 2885 |
|
|
2021
Q4 | $34.1M | Buy |
1,922,423
+60,815
| +3% | +$1.08M | ﹤0.01% | 2558 |
|
|
2021
Q3 | $42.9M | Buy |
1,861,608
+672,778
| +57% | +$15.5M | ﹤0.01% | 2445 |
|
|
2021
Q2 | $27.7M | Sell |
1,188,830
-117,091
| -9% | -$2.73M | ﹤0.01% | 2676 |
|
|
2021
Q1 | $40.7M | Buy |
1,305,921
+454,083
| +53% | +$14.1M | ﹤0.01% | 2426 |
|
|
2020
Q4 | $33.9M | Buy |
+851,838
| New | +$33.9M | ﹤0.01% | 2389 |
|